These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3189169)

  • 1. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension.
    Jeunemaitre X; Charru A; Chatellier G; Degoulet P; Julien J; Plouin PF; Corvol P; Ménard J
    Am J Cardiol; 1988 Nov; 62(16):1072-7. PubMed ID: 3189169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia.
    Jackson PR; Ramsay LE; Wakefield V
    Br J Clin Pharmacol; 1982 Aug; 14(2):257-63. PubMed ID: 7104176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial.
    Damian DJ; McNamee R; Carr M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):188. PubMed ID: 27716064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Properties and indications of potassium-sparing diuretics].
    Rorive G; Krzesinski JM
    Rev Med Liege; 1986 May; 41(9):330-6. PubMed ID: 3523669
    [No Abstract]   [Full Text] [Related]  

  • 5. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of spironolactone in essential hypertension.
    Jeunemaitre X; Chatellier G; Kreft-Jais C; Charru A; DeVries C; Plouin PF; Corvol P; Menard J
    Am J Cardiol; 1987 Oct; 60(10):820-5. PubMed ID: 3661395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of potassium balance during diuretic therapy.
    Kohvakka A; Eisalo A; Manninen V
    Acta Med Scand; 1979; 205(4):319-24. PubMed ID: 373393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension.
    Garcá Puig J; Miranda ME; Mateos F; Herrero E; Lavilla P; Gil A
    J Clin Pharmacol; 1991 May; 31(5):455-61. PubMed ID: 2050832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential hypertension: new insights and controversies in treatment with diuretics.
    Houston MC; Johnston PE
    South Med J; 1986 Aug; 79(8):984-90. PubMed ID: 3526575
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma electrolytes in elderly patients taking fixed combination diuretics.
    Bayer AJ; Farag R; Browne S; Pathy MS
    Postgrad Med J; 1986 Mar; 62(725):159-62. PubMed ID: 3714599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient conversion of treatment to potassium-sparing diuretics.
    Ridgeway NA; Ginn DR; Alley K
    Am J Med; 1986 May; 80(5):785-8. PubMed ID: 3706365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T; Yalçin AU
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of spironolactone and amiloride combined with hydrochlorothiazide in the treatment of slight or moderate hypertension].
    Sanguigni D; Benvenuti C
    Clin Ter; 1978 Oct; 87(1):69-74. PubMed ID: 737980
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive, saluretic and hypokalaemic effects of cyclothiazide in comparison with hydrochlorthiazide with amiloride supplement.
    Salonen JT; Ylitalo P
    Eur J Clin Pharmacol; 1982; 22(6):495-9. PubMed ID: 7128662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene.
    Kohvakka A
    Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):273-7. PubMed ID: 3045028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Principles of treating hypertension patients with diuretics].
    Nekrasova AA
    Ter Arkh; 1986; 58(1):116-20. PubMed ID: 3961683
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrochlorothiazide and potassium chloride in comparison with hydrochlorothiazide and amiloride in the treatment of mild hypertension.
    Andersen B; Snorrason SP; Ragnarsson J; Hardarson T
    Acta Med Scand; 1985; 218(5):449-54. PubMed ID: 3911735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrochlorothiazide and spironolactone in hypertension.
    Schrijver G; Weinberger MH
    Clin Pharmacol Ther; 1979 Jan; 25(1):33-42. PubMed ID: 363334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.